U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Tacrolimus Capsules
Status: Resolved
»Duration of Shortage: 05/17/2019 - 05/02/2022
»Therapeutic Categories: Transplant

Expand all

Accord Healthcare Inc. (Revised 05/02/2022)

Company Contact Information:
866-941-7875, option 2

Presentation
  • 0.5 mg 100 count (NDC 1672904101)
  • 1 mg 100 count (NDC 1672904201)
  • 5 mg 100 count (NDC 1672904301)
Note:
  • Available

Ascend Laboratories LLC. (Revised 05/02/2022)

Company Contact Information:
860-667-7081

Presentation
  • 0.5 mg 100’s count (NDC 67877-278-01)
  • 1 mg 100’s count (NDC 67877-279-01)
  • 5 mg 100’s count (NDC 67877-280-01)
Note:
  • Available

Astellas (Revised 05/02/2022)

Company Contact Information:
800-727-7003

Presentation
  • PROGRAF® (tacrolimus) capsules 0.5 mg 100 count bottle (NDC 0469-0607-73)
  • PROGRAF® (tacrolimus) capsules 5 mg 100 count bottle (NDC 0469-0657-73)
  • PROGRAF® (tacrolimus) capsules 1 mg 100 count bottle (NDC 0469-0617-73)
  • ASTAGRAF XL® (tacrolimus extended release capsules) 0.5 mg 30 count bottle (NDC 0469-0647-73)
  • ASTAGRAF XL® (tacrolimus extended release capsules) 1 mg 30 count bottle (NDC 0469-0677-73)
  • ASTAGRAF XL® (tacrolimus extended release capsules) 5 mg 30 count bottle (NDC 0469-0687-73)
  • PROGRAF® Granules (tacrolimus for oral suspension) 0.2 mg unit dose packets (NDC 0469-1230-50)
  • PROGRAF® Granules (tacrolimus for oral suspension) 1 mg unit dose packets (NDC 0469-1330-50)
Note:
  • Available

BPI Labs, LLC (Revised 05/02/2022)

Company Contact Information:
727-471-0850 ext. 275

Presentation
  • 1 mg 100 count bottle (NDC 54288-135-01)
Note:
  • Available

Dr. Reddy's Laboratories, Inc. (Revised 05/02/2022)

Company Contact Information:
866-733-3952

Presentation
  • 0.5 mg (NDC 55111-525-01)
  • 1 mg (NDC 55111-526-01)
  • 5 mg (NDC 55111-527-01)
Note:
  • Available

Glenmark Pharmaceuticals (Revised 05/02/2022)

Company Contact Information:
888-721-7115

Presentation
  • 0.5 mg 100 count bottles (NDC 68462-685-01)
  • 1 mg 100 count bottles (NDC 68462-686-01)
  • 5 mg 100 count bottles (NDC 68462-687-01)
Note:
  • Available

Mylan Pharmaceuticals Inc., a Viatris Company (Revised 05/02/2022)

Company Contact Information:
800-796-9526

Presentation
  • 0.5 mg, 100s (NDC 0378-2045-01)
  • 1 mg, 100s (NDC 0378-2046-01)
  • 5 mg, 100s (NDC 0378-2047-01)
Note:
  • Available

Sandoz (Revised 05/02/2022)

Company Contact Information:
800-525-8747

Presentation
  • 0.5 mg 100 count bottle (NDC 0781-2102-01)
  • 1 mg 100 count bottle (NDC 0781-2103-04)
  • 5 mg 100 count bottle (NDC 0781-2104-01)
Note:
  • Available

Strides Pharma Inc. (Revised 05/02/2022)

Company Contact Information:
855-273-0146

Presentation
  • 1 mg 100 count bottles (NDC 64338-721-06)
  • 0.5 mg 100 count bottles (NDC 64380-720-06)
  • 5 mg 100 count bottles (NDC 64380-722-06)
Note:
  • Available

Veloxis Pharmaceuticals, Inc. (Revised 05/02/2022)

Company Contact Information:
919-591-3085

Presentation
  • Envarsus XR 0.75 mg Extended-Release Tablets 30 count (NDC 68992-3075-3)
  • Envarsus XR 0.75 mg Extended-Release Tablets 100 count (NDC 68992-3075-1)
  • Envarsus XR 1 mg Extended-Release Tablets 30 count (NDC 68992-3010-3)
  • Envarsus XR 1 mg Extended-Release Tablets 100 count (NDC 68992-3010-1)
  • Envarsus XR 4 mg Extended-Release Tablets 30 count (NDC 68992-3040-3)
  • Envarsus XR 4 mg Extended-Release Tablets 100 count (NDC 68992-3040-1)
Note:
  • Available
Back to Top